Steven C. Stoner, Pharm.D., BCPP
Chair, Division of Pharmacy Practice and Administration
UMKC School of Pharmacy
2464 Charlotte Street
Kansas City, MO 64108
Northwest Missouri Psychiatric Rehabilitation Center
3505 Frederick Avenue
St. Joseph, MO 64506
Dr. Stoner received his doctor of pharmacy degree from the University of Nebraska Medical Center College of Pharmacy in 1994. He has been with UMKC since 1996 when he joined as a clinical assistant professor, following his post-doctoral completion of a one-year ASHP accredited psychiatric pharmacy practice and administration residency and a one-year fellowship at Western Missouri Mental Health Center in Kansas City, Missouri. In 1997 he was awarded an NCDEU-NIMH Young Investigator Award and in 2001 the CPNP AstraZeneca Clinical Pharmacy Practice & Administration Award. Dr. Stoner has also been the recipient of both teaching and preceptor of the year awards while at UMKC. In 2006, he completed the American Association of Colleges of Pharmacy Academic (AACP) Leadership Fellows Program. Dr. Stoner has been a member of CPNP since 1997 and has served for four years on the Recertification Committee and has been elected to the board of directors as member-at-large. He also is a member of the American Society of Health-System Pharmacists (ASHP), the Missouri Society of Health-System Pharmacists (MSHP), and served as the director of an ASHP accredited psychiatric pharmacy practice and administration residency program for 10 years (1998-2008). In addition, he has served as president of the Mid-America Colleges of Clinical Pharmacy (MACCP).
Stoner SC, Berry A. Suspected Neuroleptic Malignant Syndrome During Quetiapine-Clozapine Cross Titration. The Journal of Pharmacy Practice & Administration, Online First, March 24, 2009 as doi:10.1177/0897190009333412.
Stoner SC, Deal E, Lurk J. Divalproex Sodium Associated Neutropenia. Annals of Pharmacotherapy 2008; 42:1507-1510.
Dahmen MM, Stoner SC, Khan R. Clozapine Rechallenge Following Bowel Obstruction. Submitted to the Journal of Pharmacy Practice & Administration, Online First, October 24, 2008 as doi:10.1177/0897190008326103.
Stoner SC, Dahmen MM, Berges A. Aripiprazole Augmentation with Clozapine. Pharmacotherapy 2007; 27(11): 1599-1602.
Stoner SC, Dahmen MM. Divalproex Sodium Extended-Release in the Management of Mania in Bipolar Disorder. Neuropsychiatric Disease and Treatment 2007; 3(6): 839-846.
Stoner SC, Lea JW, Dodson T, Johnson C. Hyponatremia Following the Chronic Use of Hydrochlorothiazide in Combination with Celecoxib. Case report submitted to the Annals of Pharmacotherapy, December 2006. Not Accepted
Lea JW, Stoner SC (Corresponding Author). Aripiprazole Associated Agitation Following Aripiprazole Initiation. Pharmacotherapy 2007; 27(9): 1339-1342.
Piascik P, Bernard D, Madhavan S, Sorensen TD, Stoner SC, TenHoeve, T. Gifts and Corporate Influence in Doctor of Pharmacy Education: Current Practices and Recommendations. Accepted by the American Journal of Pharmaceutical Education 2007; 71(4): 1-8.
Stoner SC, Nelson LA, Lea JW, Marken PA, Sommi RW, Dahmen MM. Historical Review of Carbamazepine in Bipolar Disorder. Pharmacotherapy 2007; 27(1): 68-88.
Principal Investigator. Prospective Evaluation of Requip Associated Psychotic Symptoms in an Outpatient Population Treated for Restless Leg Syndrome and Parkinson’s Disease. Accepted by GlaxoSmithKline Research and Development for funding.
American Colleges of Clinical Pharmacy, Academic Leadership Fellows Program, Awarded for 2005-2006.
Principal Investigator. A Review of the Use of Extended-Release Divalproex Sodium for Psychiatric and Mood Related Disorders. Accepted by Abbott Pharmaceuticals for funding.
Recent national and regional presentations
“Antidepressants and Suicidality: Separating Fact from Fiction,” presented at the CPNP Annual Midyear Meeting, Jacksonville, Florida. April 2009.
“Antidepressants and Suicidality: Separating Fact from Fiction,” presented at the 43rd Annual ASHP Midyear Meeting, Orlando, Florida, December 8, 2008.
“Psychotropic Use in Children,” presented at the Annual Missouri CASA Association Meeting, Lake Ozark, Missouri, October 17, 2008.
“Evaluation of Drug Induced Movement Disorders” and “Psychotropics Made Simple,” presented to State of Missouri Department of Corrections employees, Missouri Department of Corrections Annual Meeting, Lake Ozark, Missouri, September 18, 2008.
“Turning Clinical Practice Into Research,” symposia presented at the AACP Annual Meeting, Chicago, Illinois, July 22, 2008.
“Maintenance Management of Bipolar Disorder,” presented to pharmacists at the Minnesota Multistate Contracting Alliance for Pharmacy Annual Meeting, MMCAP Annual Meeting, Rochester, Minnesota, May 13-15, 2008.
“Claimbusters: Resolving Clinical Controversies with Atypical Antipsychotics,” presented as an industry sponsored symposia, College of Psychiatric and Neurologic Pharmacists Annual Meeting, Scottsdale, Arizona, April 13-16, 2008